What are monoclonal antibodies?

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses.
Casirivimab and imdevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2, designed to block the virus’ attachment and entry into human cells.

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.

Is this the same treatment Donald Trump received?

This is the same type of treatment the president recieved.

Is it available here in the Coastal Bend?

Yes! We have two locations offering the treatment study, those locations are in Corpus Christi & Victoria Texas.

What do our patients say?

We haven’t had any complaints, in fact we have received many patients thanking us for providing the treatment locally. Usually in just a matter of days most patients symptoms are little to none. help patients to get back to work and back with their families sooner!

Who qualifies for this treatment?

We are currently looking for people who are CURRENTLY positive for COVID19.
We are also looking for people who are negative but can provide proof that they live with somebody who CURRENTLY is positive.

What is the time commitment?

The time commitment is around 30-85 days for positive patients & around 225 days for those who are negative but living with a positive patient. It is important that volunteers finish the study in order to provide accurate data. We can offer work excuses and we offer compensation for time and travel.

What does the first visit look like?

The first visit is the longest visit, its about 3-4 hours. The first visit will include details about the study and making sure you understand the treatment and research. There will be a Doctor, Nurse & Coordinator in the room with you to ensure your safety and questions are answered. We will collect vitals and demographic information, once you are comfortable and agree to proceed further we will begin a infusion by IV of the monoclonal antibodies, this takes about an hour. Then we will monitor you for about 2-3 hours to ensure no reactions occur. We suggest you come hydrated and rested.

Copyright © 2020 Crossroads Clinical Research